Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Instagram
  • Listen to CMAJ podcasts
Practice

Infantile hemangiomas

Katia Faustini and Joseph M. Lam
CMAJ April 16, 2013 185 (7) 586; DOI: https://doi.org/10.1503/cmaj.121156
Katia Faustini
From the Faculty of Medicine (Faustini), McGill University, Montréal, Que.; and the Departments of Pediatrics and of Dermatology and Skin Sciences (Lam), University of British Columbia, Vancouver, BC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph M. Lam
From the Faculty of Medicine (Faustini), McGill University, Montréal, Que.; and the Departments of Pediatrics and of Dermatology and Skin Sciences (Lam), University of British Columbia, Vancouver, BC
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF
Loading

Infantile hemangiomas are the most common type of vascular tumour in children

Infantile hemangiomas present in about 4%–5% of infants, with predominance in female, preterm and white infants.1 They may present as superficial (Figure 1), subcutaneous (deep) or mixed lesions. Although they are most common in the head and neck region, they may appear anywhere on the skin or mucous membranes. Infantile hemangiomas differ from congenital hemangiomas in that they are often not present at birth, but appear within the first few days to months of life.

Figure 1:
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1:

Multiple vascular papules and plaques are a marker for visceral involvement.

Most infantile hemangiomas require only observation

The natural history of hemangiomas involves early proliferation in which 80% of the growth occurs during the infant’s first 3 months of life. After the infant is about 1 year of age, most hemangiomas undergo an involution period that progresses at a rate of 10% per year.2 Deep hemangiomas may have a longer growth and involution period. About 85%–90% of infantile hemangiomas will resolve completely by the time the child is 10 years of age, typically with minimal residual findings, and do not require treatment.

A subset of hemangiomas can cause problems

Whereas most hemangiomas require only observation, certain hemangiomas can be potentially limb- or life-threatening. Periorbital lesions may lead to complications such as astigmatism and optic atrophy, and laryngeal and tongue lesions can cause swallowing or respiratory impairment. Cosmetic disfigurement can occur with nasal-tip lesions. Hemangiomas may ulcerate, causing pain and bleeding. Certain cutaneous hemangiomas may be markers for underlying congenital anomalies (Figure 1).3,4 For example, lumbosacral segmental hemangiomas are associated with underlying spinal cord tethering and myelopathy, as well as other abnormalities.4 Multiple hemangiomas (> 5) are a marker for visceral involvement.5

Infants with problematic hemangiomas should be referred early

Infants with hemangiomas require close observation during the first few weeks to months of life. Whereas most hemangiomas can be simply observed, infants with potentially problematic hemangiomas require rapid referral, ideally within this critical growth period. Referrals for high-risk hemangiomas that are growing should be considered urgent rather than routine by both the referring and the consulting physicians.

Problematic hemangiomas can be effectively treated

Among experts, propranolol is becoming a first-line systemic treatment for problematic hemangiomas.6 It acts by inhibiting the growth phase of hemangiomas.7 Case series and randomized controlled studies have shown its benefit over systemic corticosteroids.8 It should be administered by an expert familiar with its use. Second-line treatments include systemic corticosteroids, α-interferon and vincristine.5 Pulse-dye laser is effective for superficial and ulcerated hemangiomas,5 whereas topical timolol maleate gel shows promise in treating superficial lesions.9

Footnotes

  • Competing interests: None declared.

  • This article has been peer reviewed.

  • For references, please see Appendix 1, available at www.cmaj.ca/lookup/suppl/doi:10.1503/cmaj.121156/-/DC1

PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 185 (7)
CMAJ
Vol. 185, Issue 7
16 Apr 2013
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Infantile hemangiomas
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Infantile hemangiomas
Katia Faustini, Joseph M. Lam
CMAJ Apr 2013, 185 (7) 586; DOI: 10.1503/cmaj.121156

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Infantile hemangiomas
Katia Faustini, Joseph M. Lam
CMAJ Apr 2013, 185 (7) 586; DOI: 10.1503/cmaj.121156
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Infantile hemangiomas are the most common type of vascular tumour in children
    • Most infantile hemangiomas require only observation
    • A subset of hemangiomas can cause problems
    • Infants with problematic hemangiomas should be referred early
    • Problematic hemangiomas can be effectively treated
    • Footnotes
  • Figures & Tables
  • Responses
  • Metrics
  • PDF

Related Articles

  • Highlights
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • SARS-CoV-2 vaccination in pregnancy
  • Infantile perianal pyramidal protrusion
  • Topical nonsteroidal anti-inflammatory drugs
Show more Practice

Similar Articles

Collections

  • Article Types
    • Five Things to Know About
  • Topics
    • Dermatology
    • Pediatrics

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected]

CMA Civility, Accessibility, Privacy

 

Powered by HighWire